Mumbai (Maharashtra) [India], Aug 10 (ANI): The Indian government's recent incentives to boost domestic manufacturing of active pharmaceutical ingredients (APIs) and key starting materials (KSMs) can improve backward integration over the next few years and curtail supply-chain disruption ris